Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sincere CoTSE:7782 +0.21%77 Market Cap is 円3,080 Mil as of Aug. 17, 2026. GuruFocus rates TSE:7782 with a GF Score™ of 77/100 and a GF Value™ of 円689.09 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 859 Medical Devices & Instruments companies, Sincere Co ranks worse than 77.3% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Sincere Co's share price for the quarter that ended in Dec. 2025 was 円506. Sincere Co's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 7 Mil. Therefore, Sincere Co's market cap for the quarter that ended in Dec. 2025 was 円3,306 Mil.
Sincere Co's quarterly market cap
increased
from Jun. 2025 (円3,639 Mil) to Sep. 2025 (円3,796 Mil) but then
declined
from Sep. 2025 (円3,796 Mil) to Dec. 2025 (円3,306 Mil).
Sincere Co's annual market cap
declined
from Dec. 2023 (円3,413 Mil) to Dec. 2024 (円3,105 Mil) but then
increased
from Dec. 2024 (円3,105 Mil) to Dec. 2025 (円3,306 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Sincere Co's Enterprise Value for Today is 円3,206 Mil.
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Sincere Co Market Cap Related Terms
Sincere Co Market Cap Historical Data
* Premium members only.
The historical data trend for Sincere Co's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:7782 vs ISRG, BDX, MDLN: Market Cap Comparison
For the Medical Instruments & Supplies subindustry, Sincere Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sincere Co Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sincere Co's Market Cap distribution charts can be found below:
* The bar in red indicates where Sincere Co's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Sincere Co's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sincere Co (TSE:7782) has a Market Cap of 円3,080 Mil as of Aug. 17, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Sincere Co and its competitors. According to the industry distribution chart, Sincere Co ranks #664 out of 859 companies in the Medical Devices & Instruments industry, placing it in the top 77.3%.
Is Sincere Co's Market Cap too high?
Sincere Co's current Market Cap is 円3,080 Mil. Based on the distribution chart, Sincere Co ranks #664 out of 859 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Sincere Co has a GF Score™ of 77/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sincere Co's Market Cap compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Sincere Co ranks #664 out of 859 companies for Market Cap. This places Sincere Co in the lower half of its industry. The industry median Market Cap is 120.77. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 120.77, based on 859 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Sincere Co and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 120.77 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sincere Co's current Market Cap is 円3,080 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sincere Co stock overvalued right now?
Based on GuruFocus' analysis, Sincere Co (TSE:7782) is currently considered Significantly Undervalued. The stock's GF Value™ is 円689.09, compared to a current price of 円472.00 — trading 31.5% below its estimated fair value. The current Market Cap is 円3,080 Mil. Sincere Co's overall GF Score™ is 77/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Sincere Co (TSE:7782), the current Market Cap is 円3,080 Mil as of Aug. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sincere Co (TSE:7782) Overvalued in 2026?
Based on GuruFocus' analysis, Sincere Co stock appears to be undervalued.
The current stock price of 円472.00 is trading 31.5% below its estimated GF Value™ of 円689.09.
GuruFocus considers Sincere Co to be Significantly Undervalued.
Key valuation signals for TSE:7782:
Market Cap: 円3,080 Mil
GF Value™: 円689.09 vs. price of 円472.00 (31.5% below fair value)
No single metric tells the full story. See the TSE:7782 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sincere Co Ltd is a Japanese firm engaged in the manufacturing and sale of contact lens.As a company that manufactures and sells contact lenses, which are high-regulated medical devices, it place the highest priority on product safety and quality control, while working closely with company's customers to develop a variety-of-products and sell them at affordable prices to please as many customers as possible. The company opperates domestically as well as internationally.
77GF Score
Get the complete analysis for TSE:7782
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7782 has been successfully added to your 
